granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
-9.30 -138.48 Change +/(-) Unit : million baht • Revenue of Q 1/2019 is less than of both Q 4/2018 and Q1/2018 because of the followings: o Low purchasing power in domestic market causes our domestic
. Statement of Comprehensive Income Total Revenues (Million Baht) Quarterly Change 1/2019 1/2018 % Sales Domestic Sales 88.4 106.6 (17.1) Export Sales 295.8 295.2 0.2 Total Sales 384.2 401.8 (4.4) Foreign
baht or 0.4 percent compared to non-current assets as of December 31, 2018. The major change was mainly from the decreased of investment property 0.9 million baht. 2 (2) Total Liabilities Company total
nearly the same, there is no significant change. Service Income In 2019, the company’s and subsidiaries’ service income was totally Baht 5.94 million, whereas none of them in 2018, increasing Baht 5.94
financial instruments 100.85 (33.27) 100.72 (33.40) Shares of gain from investments in an associate and a joint venture 1.23 2.54 0.00 0.00 Gain from change in a joint venture proportion 0.00 (8.80) 0.00 0.00
percent compared to non-current assets as of December 31, 2017. The major change was mainly from the dereased of Investment Property 13.8 million baht while Cost of landfill preparation increased 7.9
change in a joint venture proportion - (8.80) - - Other income 22.44 6.77 25.14 6.77 Total income 961.23 (179.41) 959.77 (175.20) The Company would like to inform the reasons for change of revenues as
foreign exchange, the Company reported net loss of Baht 102.0 million. Loss per share reported at Baht 4.78. Statement of Comprehensive Income Total Revenues (Million Baht) Quarterly Change 1/2020 1/2019